N
MTEM

Nuveen’s Molecular Templates, Inc. MTEM Stock Holding History

Nuveen’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,243
Closed -$348K – 3570
2022
Q1 		$348K Buy
9,243
+144
+2% +$6.36K ﹤0.01% 3092
2021
Q4 		$491K Sell
9,099
-3,282
-27% -$246K ﹤0.01% 3077
2021
Q3 		$1.25M Sell
12,381
-439
-3% -$45.3K ﹤0.01% 2904
2021
Q2 		$1.5M Buy
12,820
+4,831
+60% +$632K ﹤0.01% 2834
2021
Q1 		$1.51M Sell
7,989
-1,088
-12% -$191K ﹤0.01% 2739
2020
Q4 		$1.28M Sell
9,077
-3,100
-25% -$458K ﹤0.01% 2716
2020
Q3 		$2M Buy
12,177
+822
+7% +$146K ﹤0.01% 2390
2020
Q2 		$2.35M Buy
11,355
+3,372
+42% +$783K ﹤0.01% 2273
2020
Q1 		$1.59M Buy
7,983
+3,446
+76% +$754K ﹤0.01% 2297
2019
Q4 		$951K Buy
4,537
+1,382
+44% +$199K ﹤0.01% 2702
2019
Q3 		$311K Hold
3,155
– – ﹤0.01% 3045
2019
Q2 		$395K Buy
+3,155
New +$343K ﹤0.01% 3072

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen's MTEM Position: Q2 2022 in Review

Nuveen sold out of Molecular Templates, Inc. (MTEM) in Q2 2022, closing a stake of 9,243 shares — an estimated $348K sold.

Nuveen first reported a position in MTEM in Q2 2019 and held it in 12 quarters. The position peaked at $2.35M in Q2 2020. 65 funds tracked by Wall St. Rank hold MTEM as of Q2 2022.

  • Nuveen reported no remaining Molecular Templates, Inc. position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 9,243 Molecular Templates, Inc. shares in Q2 2022, an estimated $348K.
  • Nuveen first reported a position in Molecular Templates, Inc. in Q2 2019 and held it in 12 quarters.
  • Nuveen's Molecular Templates, Inc. position peaked at $2.35M in Q2 2020.
  • 65 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.